Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of ...

Radical Catheter Technologies ™, a pioneering medical device company and a NeuroTechnology Investors (NTI) portfolio company focused on advancing the next ...

Q’Apel Medical, Inc. announced it has received FDA clearance for the Zebra neurovascular access system, which is indicated fo ...

Increasing rates of neurovascular interventions spark a need for reliable access and procedural versatilityCompany expands ...

Q'Apel Medical (Q'Apel), a private medical device company focused on revolutionizing neurovascular interventions, today ...

Dr. Mohana Rao Patibandla presenting his landmark neurosurgical research at AP NEUROCON 2025, Nellore. Audience and expert panel attentivel ...

A nerve-illuminating agent to minimize surgical risk passed an early test by achieving sustained fluorescence of the ...

ABSTRACT Despite the neuroanatomy knowledge of the prostate described initially in the 1980's and the robotic surgery advantages in terms of operative view magnification, potency outcomes following ...

J&J’s potential exit from the neurovascular market follows a trend among medtech leaders such as Medtronic and Stryker, which have refocused on high-growth markets.

J&J’s potential exit from the neurovascular market follows a trend among medtech leaders such as Medtronic and Stryker, which have refocused on high-growth markets. Medtronic divested its patient ...